A fasting-mimicking diet programme reduces liver fat and liver inflammation/fibrosis measured by magnetic resonance imaging in patients with type 2 diabetes. A fasting-mimicking diet programme reduces liver fat and liver inflammation/fibrosis measured by Magnetic Resonance Imaging in patients with type 2 diabetes

A 12-month fasting-mimicking diet programme reduced liver fat (MRI-PDFF) and inflammation/fibrosis (cT1) in type 2 diabetes patients. Improvements in cT1 and PDFF correlated with reductions in HbA1c, fasting glucose, triglycerides, weight, and total cholesterol. This dietary approach shows promise as an adjunct therapy to standard diabetes care.